Cargando…
Linking the p53 tumor suppressor pathway to somatic cell reprogramming
Reprogramming somatic cells to induced pluripotent stem (iPS) cells has been accomplished by expressing pluripotency factors and oncogenes1–8, but the low frequency and tendency to induce malignant transformation9 compromise the clinical utility of this powerful approach. We address both issues by i...
Autores principales: | Kawamura, Teruhisa, Suzuki, Jotaro, Wang, Yunyuan V., Menendez, Sergio, Morera, Laura Batlle, Raya, Angel, Wahl, Geoffrey M., Belmonte, Juan Carlos Izpisúa |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2735889/ https://www.ncbi.nlm.nih.gov/pubmed/19668186 http://dx.doi.org/10.1038/nature08311 |
Ejemplares similares
-
Regeneration and reprogramming compared
por: Christen, Bea, et al.
Publicado: (2010) -
Analysis of Human and Mouse Reprogramming of Somatic Cells to Induced Pluripotent Stem Cells. What Is in the Plate?
por: Boué, Stéphanie, et al.
Publicado: (2010) -
c-MYC Triggers Lipid Remodelling During Early Somatic Cell Reprogramming to Pluripotency
por: Prieto, Javier, et al.
Publicado: (2021) -
Analysis of protein coding mutations in hiPSCs and their possible role during somatic cell reprogramming
por: Ruiz, Sergio, et al.
Publicado: (2013) -
Metabolic remodeling during somatic cell reprogramming to induced pluripotent stem cells: involvement of hypoxia-inducible factor 1
por: Ishida, Tomoaki, et al.
Publicado: (2020)